Investor Presentaiton

Clinical Evidence Electromed has Published Studies Showing Effectiveness of HFCWO to Treat Bronchiectasis Therapy with HFCWO demonstrated key health outcomes improved in post- compared to pre-index period: cough, all-cause hospitalizations, pneumonia and pulmonary hospitalizations. Dekoven (2022) 59% Fewer hospitalizations Exacerbations requiring hospitalizations reduced with SmartVestⓇ. Sievert (2016) Therapy with SmartVestⓇ significantly decreased exacerbations requiring i hospitalization, antibiotic I I use, and stabilizes lung function. Powner (2018) Therapy with SmartVestⓇ demonstrated an improvement in symptom scores and quality of life. Chakravorty (2011) smartvest AIRWAY CLEARANCE SYSTEM Investor Presentation 75% Reduction in ER visits Longitudinal outcome-based study showed ER visits significantly reduce with SmartVestⓇ. Sievert (2018) ELECTROMED, INC. | 11

View entire presentation